Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125702171 | 12570217 | 1 | I | 20151007 | 20151009 | 20160719 | 20160719 | PER | US-MALLINCKRODT-T201504800 | MALLINCKRODT | 46.86 | YR | M | Y | 86.00000 | KG | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125702171 | 12570217 | 1 | PS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Oral | 2 ML (40 MG); SOMETIMES ANOTHER 1-2 ML AFTER 30 MINUTES | U | Y | UNKNOWN | 202348 | ORAL SOLUTION | ||||||
| 125702171 | 12570217 | 2 | C | HYDROCODONE | HYDROCODONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125702171 | 12570217 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125702171 | 12570217 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125702171 | 12570217 | Hallucination | |
| 125702171 | 12570217 | Panic attack | |
| 125702171 | 12570217 | Respiratory rate decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125702171 | 12570217 | 1 | 20151007 | 0 |